Skip to content
healthcare.dev

Zytiga

NDC 57894-150, abiraterone acetate, tablet, from Janssen Biotech, Inc..

Product NDC
57894-150
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202379
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
57894-150-1257894015012120 TABLET in 1 BOTTLE (57894-150-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4e338e89-3cf2-48eb-b6e2-a06c608c6513

Use it

Look up 57894-150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.